| Product Code: ETC066706 | Publication Date: Jul 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Singapore Infectious Disease Point-of-care Testing Market was estimated at USD 106 Million in 2025 and is projected to reach USD 117 Million by 2032, growing at a CAGR of 1.4% from 2026 to 2032. This steady growth reflects an increasing emphasis on rapid diagnosis and treatment, particularly in the wake of public health crises. The market's expansion is driven by the need for quick and effective diagnostic solutions, especially in the context of infectious disease management.
This graph highlights how the Singapore Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.5% | Expansion of manufacturing activities |
| 2022 | 5.5% | Government infrastructure modernization initiatives |
| 2023 | 5.7% | Increasing smart city development projects |
| 2024 | 0.0% | Government infrastructure modernization initiatives |
| 2025 | 0.5% | Increasing industrial automation investments |
| 2026 | 1.5% | Expansion of commercial construction activities |
| 2027 | 1.2% | Rapid growth in telecom and data center sectors |
| 2028 | 2.1% | Increasing smart city development projects |
| 2029 | 2.4% | Expansion of manufacturing activities |
| 2030 | 1.9% | Expansion of transportation and logistics networks |
| 2031 | 1.3% | Increasing industrial infrastructure investments |
| 2032 | 1.5% | Increasing adoption of advanced technologies |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
In recent years, the demand for point-of-care testing (POCT) devices in Singapore has surged, primarily due to the COVID-19 pandemic's unprecedented impact. As the country gradually transitions back to normalcy, the focus on early diagnosis and containment of infectious diseases remains a top priority for healthcare providers.
Looking ahead, the Singapore Infectious Disease Point-of-care Testing Market is set to evolve, driven by technological advancements and growing public awareness of health management. The introduction of innovative testing methods, alongside sustained governmental support, positions the market for further growth as new challenges emerge.
Despite the promising outlook, certain restraints could hinder market growth. The accuracy and reliability of point-of-care testing devices remain a concern, as erroneous results can adversely affect patient management and public health strategies. Additionally, stringent regulatory requirements pose challenges for manufacturers, necessitating significant investment in compliance measures. In resource-limited settings, the financial burden of acquiring and maintaining POCT devices can further restrict market penetration.
Key trends shaping the Singapore Infectious Disease Point-of-care Testing Market include the development of more sophisticated and user-friendly diagnostic devices. Technological advancements, such as the integration of artificial intelligence in data analysis, enhance the accuracy of test results. Furthermore, the trend towards home-based testing continues to gain traction, driven by consumer demand for convenience and privacy. The increasing reliance on telehealth services is also paving the way for remote testing solutions, further broadening access.
Significant growth and investment opportunities lie in the expansion of diagnostic capabilities beyond conventional infectious diseases. Innovations in multiplex testing platforms that can detect multiple pathogens simultaneously represent a promising avenue for market growth. Additionally, as public health authorities recognize the value of POCT in outbreak management, funding initiatives to enhance testing infrastructure will likely become more prevalent, presenting opportunities for market players.
The Singapore government has actively promoted advancements in the infectious disease point-of-care testing market through various public health initiatives. By investing in research and development, and fostering collaborations between private companies and healthcare institutions, authorities aim to bolster local manufacturing capabilities of diagnostic devices. Additionally, the government encourages the adoption of innovative testing solutions to enhance national preparedness for future infectious disease outbreaks.
From 2026 to 2032, the Singapore Infectious Disease Point-of-care Testing Market is expected to experience transformative shifts. With advancements in diagnostic technologies and increased regulatory support, the market will likely adapt to emerging health challenges. The heightened awareness surrounding infectious diseases will continue to drive demand for rapid and accurate testing, paving the way for innovative solutions that align with Singapore's proactive healthcare strategies.
Recent developments in the Singapore Infectious Disease Point-of-care Testing Market include the launch of new rapid diagnostic tests designed to enhance the accuracy of results. Companies are increasingly focusing on collaborations with healthcare providers to integrate POCT into routine health assessments. Moreover, ongoing efforts to streamline regulatory processes aim to expedite the approval of novel testing devices, further contributing to the market's evolution.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Singapore Infectious Disease Point-of-care Testing Market Overview |
3.1 Singapore Country Macro Economic Indicators |
3.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Singapore Infectious Disease Point-of-care Testing Market - Industry Life Cycle |
3.4 Singapore Infectious Disease Point-of-care Testing Market - Porter's Five Forces |
3.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.6 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By Technologies, 2022 & 2032F |
3.7 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Singapore Infectious Disease Point-of-care Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Singapore Infectious Disease Point-of-care Testing Market Trends |
6 Singapore Infectious Disease Point-of-care Testing Market, By Types |
6.1 Singapore Infectious Disease Point-of-care Testing Market, By Applications |
6.1.1 Overview and Analysis |
6.1.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Applications, 2022-2032F |
6.1.3 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Tropical Disease, 2022-2032F |
6.1.4 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Liver Disease, 2022-2032F |
6.1.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Respiratory Disease, 2022-2032F |
6.1.6 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Sexual Disorders, 2022-2032F |
6.1.7 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
6.2 Singapore Infectious Disease Point-of-care Testing Market, By Technologies |
6.2.1 Overview and Analysis |
6.2.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Lateral Flow, 2022-2032F |
6.2.3 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Flow-through, 2022-2032F |
6.2.4 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Agglutination Assays, 2022-2032F |
6.2.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Solid Phase, 2022-2032F |
6.3 Singapore Infectious Disease Point-of-care Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Diagnostic Laboratories, 2022-2032F |
6.3.3 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.4 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Home-care Settings, 2022-2032F |
6.3.5 Singapore Infectious Disease Point-of-care Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Singapore Infectious Disease Point-of-care Testing Market Import-Export Trade Statistics |
7.1 Singapore Infectious Disease Point-of-care Testing Market Export to Major Countries |
7.2 Singapore Infectious Disease Point-of-care Testing Market Imports from Major Countries |
8 Singapore Infectious Disease Point-of-care Testing Market Key Performance Indicators |
9 Singapore Infectious Disease Point-of-care Testing Market - Opportunity Assessment |
9.1 Singapore Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.2 Singapore Infectious Disease Point-of-care Testing Market Opportunity Assessment, By Technologies, 2022 & 2032F |
9.3 Singapore Infectious Disease Point-of-care Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Singapore Infectious Disease Point-of-care Testing Market - Competitive Landscape |
10.1 Singapore Infectious Disease Point-of-care Testing Market Revenue Share, By Companies, 2025 |
10.2 Singapore Infectious Disease Point-of-care Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here